$8.87
0.010.11%
At close: Nov 12, 4:00 PM EST
$10.37
1.5117.07%
Pre-Market: 6:19 AM EST

The average analyst price target for Helus Pharma is $46.20, 345.4% above the current price. Of 5 analysts, 5 rate it Buy. Targets range from $22 to $70. The latest change came on Oct 22, 2026, when Wells Fargo raised its price target on Helus Pharma from $16 to $22 and kept an Overweight rating.
Price Target Range — 4 Quarters
Analyst Consensus — 5 Analysts
Rating Trend — Last 9 Months